760 related articles for article (PubMed ID: 33245961)
1. Structural insights into SARS-CoV-2 proteins.
Arya R; Kumari S; Pandey B; Mistry H; Bihani SC; Das A; Prashar V; Gupta GD; Panicker L; Kumar M
J Mol Biol; 2021 Jan; 433(2):166725. PubMed ID: 33245961
[TBL] [Abstract][Full Text] [Related]
2. Overview of SARS-CoV-2 genome-encoded proteins.
Bai C; Zhong Q; Gao GF
Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
[TBL] [Abstract][Full Text] [Related]
3. Structural biology of SARS-CoV-2 and implications for therapeutic development.
Yang H; Rao Z
Nat Rev Microbiol; 2021 Nov; 19(11):685-700. PubMed ID: 34535791
[TBL] [Abstract][Full Text] [Related]
4. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
5. Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.
Baruah C; Devi P; Sharma DK
Biomed Res Int; 2020; 2020():7234961. PubMed ID: 33102591
[TBL] [Abstract][Full Text] [Related]
6. Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank.
Wlodawer A; Dauter Z; Shabalin IG; Gilski M; Brzezinski D; Kowiel M; Minor W; Rupp B; Jaskolski M
FEBS J; 2020 Sep; 287(17):3703-3718. PubMed ID: 32418327
[TBL] [Abstract][Full Text] [Related]
7. An Overview of the Crystallized Structures of the SARS-CoV-2.
Ionescu MI
Protein J; 2020 Dec; 39(6):600-618. PubMed ID: 33098476
[TBL] [Abstract][Full Text] [Related]
8. Structure of Nonstructural Protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Mohammed MEA
Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
Malone B; Chen J; Wang Q; Llewellyn E; Choi YJ; Olinares PDB; Cao X; Hernandez C; Eng ET; Chait BT; Shaw DE; Landick R; Darst SA; Campbell EA
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33883267
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.
Liu C; Shi W; Becker ST; Schatz DG; Liu B; Yang Y
Science; 2021 Sep; 373(6559):1142-1146. PubMed ID: 34315827
[TBL] [Abstract][Full Text] [Related]
12. Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit.
Horova V; Landova B; Hodek J; Chalupsky K; Krafcikova P; Chalupska D; Duchoslav V; Weber J; Boura E; Klima M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452352
[TBL] [Abstract][Full Text] [Related]
13. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
Rajarshi K; Khan R; Singh MK; Ranjan T; Ray S; Ray S
Gene; 2021 Feb; 768():145313. PubMed ID: 33220345
[TBL] [Abstract][Full Text] [Related]
14. An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.
Chen S; Luo H; Chen L; Chen J; Shen J; Zhu W; Chen K; Shen X; Jiang H
Curr Pharm Des; 2006; 12(35):4539-53. PubMed ID: 17168760
[TBL] [Abstract][Full Text] [Related]
15. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
Kumar D; Chauhan G; Kalra S; Kumar B; Gill MS
Bioorg Chem; 2020 Nov; 104():104326. PubMed ID: 33142431
[TBL] [Abstract][Full Text] [Related]
16. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
J Med Virol; 2021 May; 93(5):2722-2734. PubMed ID: 33475167
[TBL] [Abstract][Full Text] [Related]
17. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
Saramago M; Bárria C; Costa VG; Souza CS; Viegas SC; Domingues S; Lousa D; Soares CM; Arraiano CM; Matos RG
FEBS J; 2021 Sep; 288(17):5130-5147. PubMed ID: 33705595
[TBL] [Abstract][Full Text] [Related]
18. A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites.
Jahirul Islam M; Nawal Islam N; Siddik Alom M; Kabir M; Halim MA
Immunobiology; 2023 Jan; 228(1):152302. PubMed ID: 36434912
[TBL] [Abstract][Full Text] [Related]
19. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
[TBL] [Abstract][Full Text] [Related]
20. Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro.
Silva RC; Freitas HF; Campos JM; Kimani NM; Silva CHTP; Borges RS; Pita SSR; Santos CBR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
